Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $176.7100 (-1.72%) ($176.7100 - $176.7100) on Mon. Jun. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.62% (three month average) | RSI | 61 | Latest Price | $176.7100(-1.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | UTHR declines -0.4% a day on average for past five trading days. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(35%) VYM(30%) VFMO(28%) XLP(27%) XBI(26%) | Factors Impacting UTHR price | UTHR will decline at least -1.31% in a week (0% probabilities). VIXM(-23%) VXX(-16%) UUP(-12%) BND(-4%) TLT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.31% (StdDev 2.62%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $177.72 | 5 Day Moving Average | $177.47(-0.43%) | 10 Day Moving Average | $179.04(-1.3%) | 20 Day Moving Average | $177.72(-0.57%) | To recent high | -16.1% | To recent low | 6.9% | Market Cap | $7.838b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |